Future studies will focus on identifying the intermediary players in the NOX2-BTG2 regulatory axis, and experiments employing a combinatorial approach would provide stronger evidence for the functional significance of this axis in ESCC pathogenesis. This evidence concerns the gene BTG2 and esophageal squamous cell carcinoma.